At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
MLTX MoonLake Immunotherapeutics
Not Yet Opened 03-14 16:00:00 EDT
38.55
+0.73
+1.93%
盘后38.55
+0.000.00%
16:14 EDT
High39.20
Low37.84
Vol300.10K
Open38.00
D1 Closing37.82
Amplitude3.60%
Mkt Cap2.44B
Tradable Cap1.08B
Total Shares63.28M
T/O11.54M
T/O Rate1.07%
Tradable Shares28.14M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Loading ...
Introduction
Company Name.
MoonLake Immunotherapeutics
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody for the treatment of inflammation diseases. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or axial spondyloarthritis. MoonLake Immunotherapeutics was incorporated in 2021 and is headquartered in Zug, Switzerland.